RPG Life Sciences Ltd.

Financial

	RPG Life Sciences	Orchid Pharma	Guj. Themis Biosyn
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	-11.18 %	n/a	n/a
R&D as a % of Total Sales	1.11 %	n/a	n/a
Financials
5 yr Average ROE	23.71 %	0.86 %	34.65 %
5yr average Equity Multiplier	1.34	1.61	1.29
5yr Average Asset Turnover Ratio	1.18	0.5	0.74
5yr Avg Net Profit Margin	15.65 %	0.56 %	35.51 %
Price to Book	7.62	3.16	16.92
P/E	22.1	46.93	94.23
5yr Avg Cash Conversion Cycle	-53.67 Days	52.03 Days	-112.39 Days
Inventory Days	61.98 Days	112.47 Days	22.82 Days
Days Receivable	35.4 Days	86.58 Days	70.51 Days
Days Payable	143.49 Days	159.29 Days	130.88 Days
5yr Average Interest Coverage Ratio	30.59	3.01	216.76
5yr Avg ROCE	28.37 %	3.08 %	45.66 %
5yr Avg Operating Profit Margin	20.94 %	11.84 %	47.34 %
5 yr average Debt to Equity	0.0	0.37	0.03
5yr CAGR Net Profit	35.58 %	n/a	10.07 %
5yr Average Return on Assets	17.85 %	1.2 %	26.69 %
Shareholdings
Promoter Holding	72.95 %	69.84 %	70.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.54 %	-20.12 %	-4.13 %
Change in Mutual Fund Holding (3 Yrs)	3.38 %	16.13 %	1.14 %

Business

	RPG Life Sciences	Orchid Pharma	Guj. Themis Biosyn
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 69.0 International formulations 19.0 Active Pharmaceutical Ingredient (API) 12.0 Sterile 0 Oral Formulations 0 0	Product Wise Break-Up 0 Domestic Formulations 0 International formulations 0 Sterile 27.56 Oral Formulations 72.44 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Pharmaceutical 100.0 Domestic Formulations 0 International formulations 0 Sterile 0 Oral Formulations 0 Active Pharmaceutical Ingredient (API) 0
Location Wise Break-Up	Location Wise Break-Up India 64.65 Rest of the World 35.35	Location Wise Break-Up Rest of the World 0 India 19.9 Others 80.1	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up urology 0 oncology 0 respiratory 0 neuro 0 Gastro intestinal 0 Orthopedics 0 Nephrology 0 Cardio 0 Others 100	-	-